menu_open Columnists
Madison Muller

Madison Muller

Fortune

We use cookies to provide some features and experiences in QOSHE

More information  .  Close

Novo’s main Ozempic plant cited for quality lapses by FDA

Novo has been racing to boost supplies of its drugs for obesity and diabetes after initially underestimating demand.

30.10.2024 3

Fortune

Madison Muller

Wegovy reduced Covid deaths in obese patients, study finds

The results underscore the drug’s far-reaching effects on metabolism and inflammation.

30.08.2024 1

Fortune

Madison Muller